ASAQ
Top
| Combination of | |
|---|---|
| Artesunate | antimalarial |
| Amodiaquine | antimalarial |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 944945-14-6  |
| ATC code | ? |
 (what is this?) (verify) |
|
ASAQ is a medication launched in 2007-03-01 which is a pharmaceutical formula combining artesunate and amodiaquine for an affordable treatment of malaria, devised by DNDi in partnership with Sanofi-Aventis. [1] The drug is patent free as well. [2]
References
- ^ "New, Once-a-Day Fixed-Dose Combination Against Malaria Now Available". http://www.dndi.org/cms/public_html/insidearticleListing.asp?CategoryId=166&SubCategoryId=167&ArticleId=421&TemplateId=1. 080218 dndi.org
- ^ "ASAQ - The $1 Future of Malaria Treatment « GlobaLab". http://globalab.wordpress.com/2007/02/28/asaq-the-1-future-of-malaria-treatment/. 080218 globalab.wordpress.com
 |
This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article ASAQ.
Read more